When co-administered with Tat exposure, AlloP attenuated the Tat-mediated impairment of electron flow in neuroblastoma cells and fully ameliorated Tat-mediated disruption of complexes I and II in vivo. This evidence concerns the gene TAT and neuroblastoma.